Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa
BIOGRAPHY
Date: March 5, 2025 Time: 8am EST (US) / 10am BRT (Brazil) / 3pm SAST (South Africa) / 6:30pm IST (India) / 9pm CST (Taiwan)
Testing for HIV Integrase Inhibitor Resistance: 2025 and Beyond
Speakers
-
Rami Kantor, MD, PhD
Brown University, Providence, Rhode IslandBIOGRAPHY -
Urvi Parikh, PhD
University of Pittsburgh, Pittsburgh, PennsylvaniaBIOGRAPHY -
Steve Williams, PhD
Director, Clinical Genetics R&D, Thermo Fisher ScientificBIOGRAPHY
Event Date & Time
Date: March 5, 2025
Time: 8am EST (US) / 10am BRT (Brazil) / 3pm SAST (South Africa) / 6:30pm IST (India) / 9pm CST (Taiwan)
Abstract
HIV drug resistance (HIVDR) can emerge with use of antiretroviral (ARV) drugs for HIV treatment and prevention. The increasing prevalence of drug-resistant HIV strains poses a serious threat to the progress made over the past decades in combating the HIV epidemic and can be attributed to various factors, including incomplete adherence to ARV drug regimens, suboptimal drug availability, and transmission of drug-resistant HIV strains. The World Health Organization (WHO) estimates that approximately 10% of people initiating ARV treatment (ART) globally have drug-resistant HIV strains. This webinar will bring forward the perspectives of key opinion leaders in the field of HIVDR to discuss the current state of drug resistance globally, use of HIV drug resistance testing for public health surveillance and clinical management of persons living with HIV (PLWH), and new challenges related to detection and monitoring of HIVDR..
Learning Objectives
- Discuss the increasing importance of population-level HIVDR surveillance testing and the potential of emerging resistance to integrase strand transfer inhibitors (INSTIs) to impact use of first-line dolutegravir-based ART regimens
- Explain the role of HIV drug resistance testing for clinical management of PLWH in the era of INSTIs
- State current and evolving methods for HIV drug resistance testing and the laboratory challenges posed by INSTIs
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
FEB 25, 2025 | 1:00 PM
C.E. CREDITS
Quality efforts in the clinical laboratory are always under the microscope- a hyper-focus for laboratorians from start to finish. Recognizing the external factors that affect hemostasis test...
APR 21, 2025 | 1:00 PM
C.E. CREDITS
Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to kn...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...